RINVOQ
The latest news about RINVOQ: headlines, AI summaries and the full story from every source.
- AbbVie's Rinvoq Shows Continued Repigmentation in Patients with Non-Segmental Vitiligo Through Week 76
- AbbVie Outlines Growth in SKYRIZI, RINVOQ and Pipeline Advances at Wells Fargo Conference
- AbbVie receives EU approval for Rinvoq as a treatment for non-segmental vitiligo
- AbbVie's Q1 Revenue Surpasses Expectations with Strong Performance in Immunology
- AbbVie Exceeds Quarterly Revenue and Profit Expectations as Newer Immunology Drugs Offset Humira Decline